Broad Spectrum Prophylactics for Acetylcholinesterase Inhibitors
The Medical CBRN Defense Consortium (MCDC), in collaboration with the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), has released a Request for Information (RFI) to assess industry capabilities in developing broad spectrum prophylactic medical countermeasures (MCMs) against acetylcholinesterase (AChE) inhibitors. These inhibitors, chemical agents that can severely impair nervous system
Broad Spectrum Prophylactics for Acetylcholinesterase Inhibitors Read More »

